Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

The TRACTION study is testing an immunotherapy drug (checkpoint inhibitor) given before standard chemotherapy to see if a patient's response to this "induction" treatment can predict how well they'll respond overall, helping doctors personalize treatment for advanced or recurring cervical cancer. **You may be eligible if...** - You have recurrent, metastatic, or persistent cervical cancer (squamous cell carcinoma, adenosquamous, or adenocarcinoma type) - Your cancer is not curable by surgery or radiation - You have not previously received chemotherapy for recurrent/metastatic disease - You are in good overall health (ECOG performance status 0–1) with adequate organ function **You may NOT be eligible if...** - You have already received chemotherapy for recurrent or metastatic cervical cancer - You have a serious autoimmune disease requiring systemic treatment - You have uncontrolled brain metastases - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.